Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-06 @ 3:11 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04548791
Protocol Section: NCT04548791
Start Identification Module Data
Brief Title: Study of Coagulation Factor VIIa Marzeptacog Alfa Activated in Subjects With Inherited Bleeding Disorders
Official Title: Phase 12 Study to Evaluate the Pharmacokinetics Pharmacodynamics Safety and Efficacy of Marzeptacog Alfa Activated in Treatment of Episodic Bleeding in Subjects With Inherited Bleeding Disorders
Acronym: None
Organization: Catalyst Biosciences
Organization Class: INDUSTRY
Organization Study ID: MAA-202
Start Status Module Data
Status Verified Date: 2021-12
Overall Status: TERMINATED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Catalyst Biosciences
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Catalyst Biosciences
Start Oversight Module Data 347344
Description Module: 350844
Study Last Update Post Date Type(Status Module):
Attachment: Upload